Cambridge Medical Robotics Ltd has appointed Patrick Pordage to the new post of head of marketing, as part of its plan to double in size to 100 employees by the end of this year.

News of the appointment comes just weeks after CMR unveiled its next-generation Versius universal surgical robotic concept for minimal access surgery. The cost-effective, flexible, modular system enables numerous robotic arms to be used to provide the versatility and dexterity necessary for a whole range of different laparoscopic procedures.

Pordage joins CMR from one of the region’s top technology brands – product design and development firm Cambridge Consultants – where he was marketing communications director. He was part of the management team that grew the company – regarded as one of the founding fathers of the Cambridge technology cluster – by more than 500% and established offices on three continents. Prior to that, his international career included working for global professional services firm KPMG.

“I am delighted to be joining CMR at this exciting time as it transforms itself from an ambitious start-up company into a global player that is leading the way for the UK when it comes to next-generation surgical robotics,” said Pordage.

CMR secured $20.3 million in a Series A funding round last year and is currently evaluating the ability of its Versius system to perform upper gastrointestinal, gynaecological, colorectal and renal surgery in cadaveric trials. The system has already demonstrated the ability to visualise and access all these parts of the body – and to perform tissue manipulation, suturing, needle driving and electrosurgery.

CMR has so far built 20 proprietary robotic arms, built and tested nine different variants of its fully articulated 5mm instruments, and conducted 11 usability studies. To date, the Versius system has been used by 32 surgeons.

Martin Frost, CEO, commented: “Our mission is to make surgical robotics commonplace in every hospital by providing a cost-effective, flexible, next-generation solution capable of carrying out 90% of minimal access procedures. I am very pleased to welcome Patrick to our world-class team. His track record of success in creating a global brand that leads the way in innovation – particularly when it comes to medical technology – will enable us to accelerate our growth and turn our vision into reality.”

Read more here.